Gentel Biosciences, Inc.

Madison, WI 53711

SBIR Award Summary

Total Number of Awards 6
Total Value of Awards $1.88MM
First Award Date 02/16/04
Most Recent Award Date 05/01/07

Key Personnel

Last Name Name Awards Contact
Strother Todd C. Strother 3
Nelson Bryce P Nelson 3

6 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/07 - 04/30/09

DESCRIPTION (provided by applicant): For this Phase II project, GenTel BioSurfaces proposes to create and validate a biochip-based test for the rapid and inexpensive diagnosis of common respiratory allergies. The proposed device requires approximately 10 microliters of blood, easily obtained from a simple finger stick, which will significantly r...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/01/06 - 04/30/07

DESCRIPTION (provided by applicant): For this Phase II project, GenTel BioSurfaces proposes to create and validate a biochip-based test for the rapid and inexpensive diagnosis of common respiratory allergies. The proposed device requires approximately 10 microliters of blood, easily obtained from a simple finger stick, which will significantly r...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/10/04 - 03/09/06

DESCRIPTION (provided by applicant): Biochips have become instrumental in gene expression, high throughput screening and drug discovery. While use of DNA chips has rapidly expanded, protein biochips have yet to be perfected. One reason is the complexity of protein immobilization. Potential applications of protein microarrays are numerous, includ...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 05/03/04 - 10/31/05

DESCRIPTION (provided by applicant): Since microarray biochips were invented, they have become instrumental in gene expression, high throughput screening, and drug discovery. Current glass-based biochips, however, are chemically unstable and are unable to withstand applications requiring multiple cycles, high temperature, or high pH. Application...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/15/04 - 09/30/05

GenTel BioSurfaces (GenTel) seeks to establish the technical merit and feasibility of an allergen biochip for use as a rapid, inexpensive and easy-to-use in vitro method for identifying elevated allergen-specific IgE titers in serum. This biochip is based upon a uniform gold surface that is highly amenable to chemical modification and uses a uni...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 02/16/04 - 08/15/05

DESCRIPTION (provided by applicant): This Phase I SBIR project is intended to demonstrate the utility of a system to efficiently screen small molecules for their effect on protein-DNA binding. DNA binding proteins are the fundamental regulators of gene expression through their recognition and binding to specific DNA sequences. Using therapeutics...